SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
556 $95 might be "fair price", but not enough for me, imho. Pipeline wilJGoren-5/23/1998
555 Just heard more on Bloomberg. An analyst from Spencer Clark (Calter?) is sayingAgAuUSA-5/22/1998
554 From Briefing.com.......... 08:33 ET Business Week Stocks: Amgen (AMGN 61 13/1DEER HUNTER-5/22/1998
553 Sputhead: Just heard that as well. Really hard to believe the type of numbers cruncher-5/22/1998
552 <<Rumour on CNBC about Amgen and Dupont>> "Rumor" is in AgAuUSA-5/22/1998
551 Rumour on CNBC about Amgen and Dupont...could be the reason for the accumulatioSputhead-5/22/1998
550 trevor: Any reason for the accumulation. It seems like like accumulation of Amcruncher-5/13/1998
549 Hi. Interesting medline abstract from Cell by Amgen. Anybody know about or haLuke-5/9/1998
548 Dave: Could be a place of safety compared to the Techs. Also on a relative bascruncher-5/5/1998
547 Up 1.75 today. With a jump 1+ around noon. Any ideas for a cause? Volume stiDave Williams-5/5/1998
546 Maykin Ho, Biotech Analyst for Goldman, Sachs was on Wall Street Week this FridJGoren-4/24/1998
545 Off topic RESEARCH ALERT - Vivus raised Reuters Story - April 23, 1998 13:48 esterina-4/23/1998
544 AMGN CEO on CNBC right now! They never answered the question, "what is inTweaker-4/23/1998
543 Amgen 1st qtr earnings $0.71 per share Amgen (AMGN) 57 1/4 -3/8: biotech conceSnowshoe-4/22/1998
542 New Use in Acute Myelogenous Leukemia Broadens Hematology/Oncology Indications JGoren-4/8/1998
541 Amgen's <AMGN.O> Neupogen gets FDA OK for new use THOUSAND OAKS, CalJGoren-4/8/1998
540 AMGN 58.125 (+.750) Improves Tolerance to Chemotherapy. Amgen's Neupogen gefred woodall-4/7/1998
539 AMGN's taking a breather. This is the way things -should- work. Amgen doesnJoe Sabatini-4/3/1998
538 Anybody knows, why AMGN keeps going down from 61.5+ to 58 now? After the good nGogo@SI-4/3/1998
537 Epogen still in the Top 10 of 1997... biz.yahoo.com Epogen, a booster of red bDave Williams-3/31/1998
536 Found this on (http://www.ragingbull.com). Company Profile: Amgen - "DownDEER HUNTER-3/30/1998
535 AMGN continues to hover around $ 61.00. I find this impressive. The lows are VALUESPEC-3/23/1998
534 Jacob, Thanks for sharing your experience. This market has surprised everyone,Joe Sabatini-3/19/1998
533 Hi Valuespec, Good trade. That 1.0 drop at open Wed. sure would have motivated fred woodall-3/19/1998
532 Sold my AMGN @ $ 60.94. VALUESPECVALUESPEC-3/19/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News